San Francisco, CA, United States of America

Endogena Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 6

% Expired Patents = 16.7


Forward Citations = 7

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Matthias Steger (6 out of 8 patents)

silverMedal Alex Mueller (6 out of 6 patents)

bronzeMedal Mauro Marigo (4 out of 4 patents)

4.  Bernhard Fasching (3 out of 3 patents)

5.  Daphna Mokady (3 out of 3 patents)


6 patents:

Company Overview
Endogena Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for the treatment of cardiovascular and metabolic diseases. Our innovative research and development efforts aim to address significant unmet medical needs and improve patient outcomes. Visit our website to learn more about our cutting-edge approach to drug discovery and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

6 Patents

#667 in San Francisco, CA

#10,604 in California

#45,102 in US

San Francisco, CA (US)
San Francisco, CA, United States of America
Forward Citations = 7

5 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Endogena Therapeutics, Inc.. Retrieved from https://idiyas.com/company/endogena-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…